Company Bristol-Myers Squibb Company Swiss Exchange

Company Bristol-Myers Squibb Company Swiss Exchange

BMY

US1101221083

Pharmaceuticals

Analysts' Consensus

Equities

BMY

US1101221083

Pharmaceuticals

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Group companies

Sector

Sales per region

Ratings for Bristol-Myers Squibb Company

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Group companies

Sector

Sales per region

Ratings for Bristol-Myers Squibb Company

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 16:35:20 28/06/2019 BST			5-day change	1st Jan Change
44.39 ^CHF	-0.25%		-18.16%	-18.16%

05-30	Bristol-Myers Squibb Says Breyanzi Gets FDA Approval as CAR T Cell Therapy for Mantle Cell Lymphoma	MT
05-30	Bristol Myers: FDA approval for Breyanzi	CF

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.

The United States account for 70.1% of net sales.

Number of employees: 34,100

USD in Million	2022	Weight	2023	Weight	Delta
Innovative Medicines 100.0 %	46,159	100.0 %	45,006	100.0 %	-2.50%

USD in Million	2022	Weight	2023	Weight	Delta
United States 70.1 %	31,828	69.0 %	31,555	70.1 %	-0.86%
International 28.3 %	13,497	29.2 %	12,752	28.3 %	-5.52%
Other 1.6 %	834	1.8 %	699	1.6 %	-16.19%

Managers	Title	Age	Since
Christopher Boerner CEO	Chief Executive Officer	53	31/01/15
David Elkins DFI	Director of Finance/CFO	55	19/11/19
Greg Meyers CTO	Chief Tech/Sci/R&D Officer	-	-
Kimberly McCutcheon Jablonski CMP	Compliance Officer	-	31/12/02
Estelle Vester-Blokland CTO	Chief Tech/Sci/R&D Officer	-	-
Samit Hirawat CTO	Chief Tech/Sci/R&D Officer	55	31/12/18
Robert Plenge CTO	Chief Tech/Sci/R&D Officer	53	31/10/19
Laura Hortas IRO	Public Communications Contact	-	-
Cynthia Piccirillo PRN	Corporate Officer/Principal	-	-
Cari Gallman PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Phyllis Yale BRD	Director/Board Member	66	19/11/19
Peter Arduini BRD	Director/Board Member	59	31/03/16
Derica Rice BRD	Director/Board Member	59	31/08/20
Paula Price BRD	Director/Board Member	62	31/08/20
Theodore Samuels BRD	Director/Board Member	69	20/02/17
David Elkins DFI	Director of Finance/CFO	55	19/11/19
Christopher Boerner CEO	Chief Executive Officer	53	31/01/15
Julia Haller BRD	Director/Board Member	69	19/11/19
Deepak Bhatt BRD	Director/Board Member	56	13/06/22
Karen Vousden BRD	Director/Board Member	66	31/12/17

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	2,923,100,096	2,024,918,592 ( 69.27 %)	896,000,000 ( 30.65 %)	69.27 %

Name	Equities	%	Valuation
Vanguard Fiduciary Trust Co. 9.181 %	186,067,109	9.181 %	8 317 M CHF
BlackRock Advisors LLC 6.185 %	125,355,772	6.185 %	5 603 M CHF
STATE STREET CORPORATION 4.518 %	91,571,110	4.518 %	4 093 M CHF
JPMorgan Investment Management, Inc. 4.368 %	88,525,438	4.368 %	3 957 M CHF
Capital Research & Management Co. (International Investors) 3.464 %	70,203,814	3.464 %	3 138 M CHF
Charles Schwab Investment Management, Inc. 2.650 %	53,715,966	2.650 %	2 401 M CHF
Fidelity Management & Research Co. LLC 2.100 %	42,557,702	2.100 %	1 902 M CHF
Geode Capital Management LLC 2.038 %	41,304,605	2.038 %	1 846 M CHF
BlackRock Life Ltd. 1.574 %	31,893,511	1.574 %	1 426 M CHF
Norges Bank (13F) 1.501 %	30,413,639	1.501 %	1 359 M CHF

Name	Equities	%	Valuation
Bram Bradesco Asset Management S/A DTVM 0.000233 %	4,731	0.000233 %	209 518 CHF

Name	Equities	%	Valuation
Transcend Wealth Collective LLC -	117,775	-	7 184 CHF
FourWorld Capital Management LLC -	100,000	-	6 100 CHF
Davenport & Co. LLC -	83,970	-	5 122 CHF
CapFinancial Partners LLC -	20,498	-	1 250 CHF
FIFTH THIRD BANCORP -	20,000	-	1 220 CHF
Private Advisor Group LLC -	15,000	-	915 CHF
Paradigm Financial Partners LLC -	10,000	-	610 CHF
Northwestern Mutual Wealth Management Co. -	242	-	15 CHF
OAKWORTH CAPITAL INC. -	125	-	8 CHF
Atlantic Edge Private Wealth Management LLC -	16	-	1 CHF

Name	Equities	%	Valuation
AVIDITY BIOSCIENCES, INC. 5.31%	5,075,304	5.31%	120,944,494 $
AVIDITY BIOSCIENCES, INC. 6.36%	759,145	6.36%	21,438,255 $
COMPUGEN LTD. 5.31%	4,757,058	5.31%	9,546,749 $
CELULARITY INC. 5.49%	1,195,327	5.49%	3,669,654 $

Bristol Myers Squibb Co.

Route 206 & Province Line Road

08543, Princeton

+609 252 4621

http://www.bms.com

address Bristol-Myers Squibb Company(BMY)

Name	Category and Sector
Bristol-Myers Squibb India Pvt Ltd. Bristol-Myers Squibb India Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb India Pvt Ltd. discovers, develops and delivers medicines for immuno-oncology. The company is based in Mumbai, India.	Pharmaceuticals: Major
Bristol-Myers Squibb de México S de RL de CV Bristol-Myers Squibb de México S de RL de CV Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb de México S de RL de CV is a Mexican company that manufactures and supplies pharmaceutical and nutritional products. The company is located in Mexico.	Pharmaceuticals: Major
Celgene Kappa Holdings LLC
Bristol-Myers Squibb International Co. ULC
Bristol-Myers Squibb Holdings Germany Verwaltungs GmbH
Seamair Insurance DAC
Bristol-Myers Squibb AE
Swords Laboratories Unlimited Co. Swords Laboratories Unlimited Co. Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Swords Laboratories Unlimited Co. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Swords, Ireland.	Pharmaceuticals: Major
BMS Strategic Portfolio Investments Holdings, Inc.
Bristol-Myers Squibb (Finland) Oy Ab Bristol-Myers Squibb (Finland) Oy Ab Pharmaceuticals: GenericHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb (Finland) Oy Ab is a Finnish pharmaceutical manufacturing company. The company is based in Vantaa, Finland. The company was founded in 1974. Simone Böhrer has been the CEO of the company since 2020.	Pharmaceuticals: Generic
Celgene Alpine Investment Co. LLC
Bristol-Myers Squibb SARL Bristol-Myers Squibb SARL Medical DistributorsDistribution Services Bristol-Myers Squibb SARL engages in the research, development, manufacture, and distribution of pharmaceutical products. Its therapeutic areas include immunoscience, immune-oncology, and cardiology. The company is headquartered in Rueil-Malmaison, France.	Medical Distributors
Celgene Alpine Investment Co. III LLC Celgene Alpine Investment Co. III LLC Financial ConglomeratesFinance Part of Bristol Myers Squibb Co., Celgene Alpine Investment Co. III LLC is an American company that provides investment services. The company is located in the US.	Financial Conglomerates
Westwood-Intrafin SA
BMS Forex Co.
Bristol-Myers Squibb GmbH & Co. KGaA Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The company is based in Munich, Germany. The CEO of the company is Han Steutel.	Pharmaceuticals: Major
Bristol-Myers Squibb SA (Spain)
Bristol-Myers Squibb KK Bristol-Myers Squibb KK BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb KK develops, manufactures and markets biopharmaceutical products. The company is based in Shinjuku-ku, Japan.	Biotechnology
Bristol-Myers Squibb Australia Pty Ltd. Bristol-Myers Squibb Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Australia Pty Ltd. is a biopharmaceutical company that researches, develops and markets medicines for serious diseases. The company was founded in 1930 and is headquartered in Noble Park North, Australia.	Pharmaceuticals: Major
Bristol-Myers Squibb Belgium SA Bristol-Myers Squibb Belgium SA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb Belgium SA develops, manufactures and distributes medicines. The company is based in Watermael-Boitsfor, Belgium. The CEO of the Belgian company is Paul Lacante.	Pharmaceuticals: Major
Bristol-Myers Squibb SRL Bristol-Myers Squibb SRL Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb SRL develops, manufactures and supplies pharmaceuticals. It offers diabetes, oncology, cardiovascular, neuroscience, virology, and immunology services. The company is headquartered in Rome, Italy.	Pharmaceuticals: Major
Bristol-Myers Squibb Pharmaceuticals Unlimited Co.
Bristol-Myers Squibb Canada Co. Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Canada Co. designs, develops and wholesales pharmaceutical products. The company is headquartered in Halifax, Canada.	Pharmaceuticals: Major
Bristol-Myers Squibb Holdings Ireland Unlimited Co. Bristol-Myers Squibb Holdings Ireland Unlimited Co. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Holdings Ireland Unlimited Co., a subsidiary of Bristol Myers Squibb Co., is a company headquartered in Ireland that operates as a holding company which develops medicines for serious diseases.	Pharmaceuticals: Major
JUNO THERAPEUTICS INC	Biotechnology
Bristol-Myers Squibb Pharmaceuticals Ltd. Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK.	Pharmaceuticals: Major
Bristol-Myers Squibb AB Bristol-Myers Squibb AB Medical DistributorsDistribution Services Part of Bristol Myers Squibb Co., Bristol-Myers Squibb AB is a company that wholesales medical equipment and pharmacy. The company is based in Solna, Sweden.	Medical Distributors
Bristol-Myers Squibb SA (Switzerland)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

41.09 USD

Average target price

53.19 USD

Spread / Average Target

+29.46%

Consensus

Estimates Revisions

Company calendar

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B
PFIZER, INC.	-0.45%	162B

Other Pharmaceuticals

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals